134 related articles for article (PubMed ID: 38754569)
21. Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes.
Pant T; Mishra MK; Bai X; Ge ZD; Bosnjak ZJ; Dhanasekaran A
Diab Vasc Dis Res; 2019 Jan; 16(1):57-68. PubMed ID: 30482051
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes.
Mangali S; Bhat A; Jadhav K; Kalra J; Sriram D; Vamsi Krishna Venuganti V; Dhar A
Biochem Pharmacol; 2020 Jul; 177():113948. PubMed ID: 32251680
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
24. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy.
Yu W; Gao B; Li N; Wang J; Qiu C; Zhang G; Liu M; Zhang R; Li C; Ji G; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1973-1983. PubMed ID: 27794418
[TBL] [Abstract][Full Text] [Related]
25. The interplay of inflammation, exosomes and Ca
Sanganalmath SK; Dubey S; Veeranki S; Narisetty K; Krishnamurthy P
Cardiovasc Diabetol; 2023 Feb; 22(1):37. PubMed ID: 36804872
[TBL] [Abstract][Full Text] [Related]
26. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress.
Cai W; Chong K; Huang Y; Huang C; Yin L
Redox Biol; 2024 Feb; 69():103010. PubMed ID: 38160540
[TBL] [Abstract][Full Text] [Related]
27. Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats.
Salin Raj P; Nair A; Preetha Rani MR; Rajankutty K; Ranjith S; Raghu KG
Int J Cardiol; 2023 Feb; 372():101-109. PubMed ID: 36481261
[TBL] [Abstract][Full Text] [Related]
28. Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1/PGC-1α pathway.
Diao J; Zhao H; You P; You H; Wu H; Shou X; Cheng G
Biochem Biophys Res Commun; 2021 Mar; 546():29-34. PubMed ID: 33561745
[TBL] [Abstract][Full Text] [Related]
29. Long-chain noncoding RNA-GAS5/hsa-miR-138-5p attenuates high glucose-induced cardiomyocyte damage by targeting CYP11B2.
Zhuo X; Bai K; Wang Y; Liu P; Xi W; She J; Liu J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33682891
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of long noncoding RNA GAS5 protects human cardiomyocyte-like AC16 cells against high glucose-induced inflammation by inhibiting miR-21-5p-mediated TLR4/NF-κB signaling.
Zhao J; Liu B; Li C
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1541-1547. PubMed ID: 31865425
[TBL] [Abstract][Full Text] [Related]
32. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.
Wang L; Cai Y; Jian L; Cheung CW; Zhang L; Xia Z
Cardiovasc Diabetol; 2021 Jan; 20(1):2. PubMed ID: 33397369
[TBL] [Abstract][Full Text] [Related]
33. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy.
Jiang MY; Man WR; Zhang XB; Zhang XH; Duan Y; Lin J; Zhang Y; Cao Y; Wu DX; Shu XF; Xin L; Wang H; Zhang X; Li CY; Gu XM; Zhang X; Sun DD
Mil Med Res; 2023 Dec; 10(1):63. PubMed ID: 38072993
[TBL] [Abstract][Full Text] [Related]
34. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
35. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR
Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390
[TBL] [Abstract][Full Text] [Related]
36. LncRNA and mRNA expression characteristic and bioinformatic analysis in myocardium of diabetic cardiomyopathy mice.
Zhao M; Wang T; Cai X; Li G; Li N; Zhou H
BMC Genomics; 2024 Mar; 25(1):312. PubMed ID: 38532337
[TBL] [Abstract][Full Text] [Related]
37. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition.
Chen Y; Zhang Z; Zhu D; Zhao W; Li F
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31085717
[TBL] [Abstract][Full Text] [Related]
39. Reduced reticulum-mitochondria Ca
Dia M; Gomez L; Thibault H; Tessier N; Leon C; Chouabe C; Ducreux S; Gallo-Bona N; Tubbs E; Bendridi N; Chanon S; Leray A; Belmudes L; Couté Y; Kurdi M; Ovize M; Rieusset J; Paillard M
Basic Res Cardiol; 2020 Nov; 115(6):74. PubMed ID: 33258101
[TBL] [Abstract][Full Text] [Related]
40. FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway.
Yin L; Fang Y; Song T; Lv D; Wang Z; Zhu L; Zhao Z; Yin X
J Cell Mol Med; 2019 Apr; 23(4):2558-2567. PubMed ID: 30701683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
